US20200377818A1 - Solvent free process for extraction of cholesterol from milk fat - Google Patents
Solvent free process for extraction of cholesterol from milk fat Download PDFInfo
- Publication number
- US20200377818A1 US20200377818A1 US16/634,812 US201816634812A US2020377818A1 US 20200377818 A1 US20200377818 A1 US 20200377818A1 US 201816634812 A US201816634812 A US 201816634812A US 2020377818 A1 US2020377818 A1 US 2020377818A1
- Authority
- US
- United States
- Prior art keywords
- cholesterol
- solvent
- milk fat
- separating
- adduct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N [H][C@@]12CC=C3C[C@@H](O)CC[C@]3(C)[C@@]1([H])CC[C@@]1(C)[C@@]2([H])CC[C@]1([H])[C@H](C)CCCC(C)C Chemical compound [H][C@@]12CC=C3C[C@@H](O)CC[C@]3(C)[C@@]1([H])CC[C@@]1(C)[C@@]2([H])CC[C@]1([H])[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/001—Refining fats or fatty oils by a combination of two or more of the means hereafter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/10—Refining fats or fatty oils by adsorption
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/12—Refining fats or fatty oils by distillation
Definitions
- the present invention relates to solvent free process for extracting cholesterol free of impurities from milk fat.
- the so isolated cholesterol is useful for the further preparation of vitamin D3.
- the present invention further provides pharmaceutical grade cholesterol from milk fat of high purity.
- Cholesterol having IUPAC name (3 ⁇ )-cholest-5-en-3-ol and which systematic name is 2,15-dimethyl-14-(1,5-dimethylhexyl)tetracyclo[8.7.0.02′7.011′15]heptacos-7-en-5-ol is a principal lipid sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord. It can be found in large concentrations within the liver, spinal cord, and brain. Cholesterol is an important component of the membranes of cells, providing stability and is the major precursor for the biosynthesis of steroid hormones, bile and vitamin D.
- Cholesterol can be found in egg yolk, organ meat, shrimp, squid, beef, pork, poultry, fish, wool grease, full-fat dairy products, butter, hard margarines, lard, coconut oil, ghee (clarified butter), vegetable ghee, palm oil. These sources usually contain cholesterol in its free form as well as in the esterified form.
- the most important source of cholesterol is lanolin, which is obtained from the wool of sheep.
- Raw wool contains three main impurities viz. wool grease, suint and dirt which make up to 30-40% of the fleece weight.
- the grease content of crossbred wool is about 6%.
- the wool grease is a very complex mixture consisting of esters of various long-chain fatty acids with long-chain alcohols and sterols. Wool grease is typically wax and not fat since glycerol esters are absent.
- the major part of the fatty acid present in wool grease consists of sterols; such as cholesterol, lanosterol and dihydrolanosterol with smaller amounts of other sterol derivatives.
- the other fatty acids present include normal paraffin series of C10 to C26, an iso-acid series from C10 to C28 even carbon atoms, an anteiso-acid series, with a terminal isobutyl group, with odd numbers of carbons from C9 to C31, ⁇ -hydroxy normal and iso-acids, like [R—CH(OH)—COOH] with even carbon numbers from about C12 to C32, n-alcohols from C18 to C30, Iso-alcohols from C18 to C26, anteiso-alcohols from C17 to C27 and 1,2 diols.
- the composition of fatty acids in wool grease is of complex nature given the different acids and alcohols present which can form varied esters.
- dairy products selected form raw milk, pasteurized milk, raw cream, pasteurized cream, butter oil or anhydrous fat and such like which have large levels of cholesterol.
- the content of cholesterol in milk fat can vary, typically contains 2-5 gms total cholesterol per 100 grams. Further essentially all of the cholesterol in milk fat is present as free cholesterol with only traces of cholesterol present as an ester.
- U.S. Pat. No. 5,326,579 disclose a process for the removal of cholesterol from a processed or un-processed dairy product using saponin as adsorbent at a temperature in the range of 35 ⁇ 80° C. and separating the insoluble cholesterol: saponin/diatomaceous earth by filtration or centrifugation.
- saponin as adsorbent
- 3- ⁇ -Cholesterol esters present in the milk fat are found to not complex with saponin.
- the process described in US′579 does not isolate cholesterol in esterified form.
- U.S. Pat. No. 6,129,945 disclose a process for removing free fatty acids (FFA) and preferably cholesterol from liquid anhydrous animal fats.
- the process uses a dilute solution of alkali metal base to form a salt of the FFA and then an alkali metal salt to precipitate the FFA from the animal fat.
- a cyclo dextrin is used in the process to remove cholesterol.
- the process described in US′945 includes first saponification followed by separation of FFA (cholesterol) using beta-cyclo dextrin.
- the process described in US′945 is based on relatively long reaction time process at low temperature, requires controlled use of the amount of base for saponification which otherwise is detrimental to the yield due to the losses of neutral fat by saponification.
- EP0318326 relates to a process of removing sterols from edible fat, specifically milk fat using a fixed and pulsed carbon column filled with adsorbents selected from carbon impregnated with a metal salt including zinc sulphate, zinc nitrate, zinc chloride, calcium chloride, manganese nitrate, manganese sulphate, manganese chloride; carbon impregnated with water soluble or alcohol soluble organic compounds selected from amides and nucleotides; porous glass, ceramic or plastics; aluminas, silicas, zeolites and magnesia which have/been impregnated with mineral salts and/or selected amides and nucleotides.
- a metal salt including zinc sulphate, zinc nitrate, zinc chloride, calcium chloride, manganese nitrate, manganese sulphate, manganese chloride
- carbon impregnated with water soluble or alcohol soluble organic compounds selected from amides and nucleotides
- WO2016096988 describe the process for extraction of cholesterol from milk fat which includes saponification which is carried out preferably in a solvent or a mixture of solvent (for example alcohol/water mixture) followed by extraction with at least one non-water miscible solvent at elevated temperature.
- the process of WO'988 is liquid extraction of cholesterol at elevated temperature and the yields and purity are low.
- the objectives of the present invention are met by providing cost effective, solvent free process for extraction of cholesterol from milk fat wherein the cholesterol obtained is substantially free of impurities and can be used in the preparation of vitamin D3.
- the solvent free process for extraction of cholesterol of high purity from milk fat characterized by the process steps comprising;
- the present invention provides pharmaceutical grade cholesterol of milk fat characterized by HPLC purity in the range of 95-98%.
- the present invention provides a process for production of vitamin D3 from pure cholesterol of milk fat obtained by the present invention. Accordingly, cholesterol is converted to 7-dehydrocholesterol (7-DHC; pro-vitamin D3) as per International Patent Publication No. WO 2015/170341, filed by the present Applicant, and converting 7-DHC to vitamin D3 by irradiation.
- 7-DHC 7-dehydrocholesterol
- pro-vitamin D3 7-dehydrocholesterol
- FIG. 1 depicts the chromatogram of Standard (STD) cholesterol.
- FIG. 2 depicts the chromatogram of cholesterol obtained by the present process.
- the present invention relates to solvent free process for extraction of cholesterol of high purity from milk fat.
- the present process avoids the contact of milk fat with potentially harmful solvents in the initial stages that can affect the functionality, flavour or other properties of the milk fat. Further, there is no saponification thereby preventing the use of base, which may lead to losses of the neutral fat resulting in low yields of the desired product.
- the isolated milk fat free of cholesterol is washed with water to remove traces of inorganic impurities.
- the residual Milk fat free of cholesterol can be used by the milk industry for their own applications.
- the present invention relates to cost effective, solvent free process for extraction of cholesterol of high purity from milk fat characterized by the process steps which comprises;
- the milk fat of the present invention includes skim milk such as fluid skim milk, ultra-filtered skim milk, condensed skim milk and various derivatives of skim milk, whey products such as reconstituted fluid whey, whey powder, whey protein isolates, whole milk, reduced fat, reconstituted non-fat dry milk and the like that contribute significant amounts of cholesterol in these foods.
- the content of cholesterol typically ranges from 2-5 gms per gm of the milk fat.
- the process comprises heating the sterol containing un-saponified milk fat with anhydrous calcium chloride in molar ratio ranging between about 1:2 to about 1:20, in solvent free medium, to obtain addition product of free cholesterol.
- the heating is performed at temperature in the range of 40 ⁇ 90° C., preferably 40-80° C., most preferably 75-85° C. for a period of 2-10 hours.
- the reaction mass is then cooled to 40-50° C. and maintained at same temperature for 10-36 hours and filtered.
- the cholesterol adduct is suspended in organic solvent and refluxed for 1-10 hours, preferably 1-5 hours, more preferably 2-4 hours.
- the reaction mass is cooled to 0-50° C., preferably at 15-45° C., more preferably at 20-30° C., stirred at same temperature for about 2-3 hours, filtered, washed further with organic solvent and dried under vacuum to obtain cholesterol.
- the isolated crude cholesterol is further purified by crystallization in solvent selected from lower alcohols such as methanol, ethanol, n-propanol, IPA, n-butanol, isobutanol or tert-butanol, preferably methanol or ketones selected from acetone, 2-Butanone, methyl isobutyl ketone, preferably acetone.
- solvent selected from lower alcohols such as methanol, ethanol, n-propanol, IPA, n-butanol, isobutanol or tert-butanol, preferably methanol or ketones selected from acetone, 2-Butanone, methyl isobutyl ketone, preferably acetone.
- the residual milk fat free of cholesterol obtained after filtration of cholesterol-calcium chloride adduct satisfies the quality standard required by the Milk industry and can be used by Milk industry for their own applications.
- the cholesterol obtained by the present process is substantially free of impurities and is characterized by HPLC purity in the range of 95-99% as depicted in the comparative tables 1 and 2 below.
- the pharmaceutical grade cholesterol can be used as precursor for further preparation of vitamin D3.
- the process for preparation of vitamin D3 from pharmaceutical grade cholesterol obtained from milk fat of the present invention which comprises (a) converting cholesterol to 7-dehydrocholesterol (7-DHC; pro-vitamin D3) as per International Patent Publication No. WO 2015/170341, filed by the present Applicant, and (ii) converting 7-DHC to vitamin D3 by irradiation.
- the milk fat used for extraction of cholesterol is not exposed to solvents in the initial stages due to which the functionality, flavour or other properties of the milk fat are not disturbed; there is no saponification thereby preventing the use of base, which may lead to losses of the neutral fat resulting in low yields of the desired product; the residual milk fat free of cholesterol of good quality can be used by the Milk Industry for further applications according to their requirement.
- the cholesterol obtained by the present process is of pharmaceutical grade and can be used as precursor for further preparation of vitamin D3. The process is simple and industrially feasible with minimum work up steps.
- Milk fat (100 gms) and anhydrous calcium chloride (8.5 gms) were heated at 80° C. for 2-4 hours.
- the reaction mass was cooled to 45° C. and maintained at same temperature for 15 hours.
- the reaction mass was filtered at 45° C., and the solid residue of cholesterol-adduct was suspended in methanol (100 ml).
- the reaction mass was refluxed for 4-6 hours, cooled to 25-30° C., stirred at same temperature for 2-3 hours, filtered and washed with methanol (10 ml) to obtain crude cholesterol.
- the crude cholesterol was recrystallized by dissolving in methanol (100 ml), filtered, washed with 20-50 ml of cold Methanol, dried under vacuum at 45° C. to obtain pure cholesterol.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
Abstract
Description
- The present invention relates to solvent free process for extracting cholesterol free of impurities from milk fat. The so isolated cholesterol is useful for the further preparation of vitamin D3. The present invention further provides pharmaceutical grade cholesterol from milk fat of high purity.
- Cholesterol, having IUPAC name (3β)-cholest-5-en-3-ol and which systematic name is 2,15-dimethyl-14-(1,5-dimethylhexyl)tetracyclo[8.7.0.02′7.011′15]heptacos-7-en-5-ol is a principal lipid sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord. It can be found in large concentrations within the liver, spinal cord, and brain. Cholesterol is an important component of the membranes of cells, providing stability and is the major precursor for the biosynthesis of steroid hormones, bile and vitamin D.
- Cholesterol can be found in egg yolk, organ meat, shrimp, squid, beef, pork, poultry, fish, wool grease, full-fat dairy products, butter, hard margarines, lard, coconut oil, ghee (clarified butter), vegetable ghee, palm oil. These sources usually contain cholesterol in its free form as well as in the esterified form.
- The most important source of cholesterol is lanolin, which is obtained from the wool of sheep. Raw wool contains three main impurities viz. wool grease, suint and dirt which make up to 30-40% of the fleece weight. The grease content of crossbred wool is about 6%. The wool grease is a very complex mixture consisting of esters of various long-chain fatty acids with long-chain alcohols and sterols. Wool grease is typically wax and not fat since glycerol esters are absent. The major part of the fatty acid present in wool grease consists of sterols; such as cholesterol, lanosterol and dihydrolanosterol with smaller amounts of other sterol derivatives. The other fatty acids present include normal paraffin series of C10 to C26, an iso-acid series from C10 to C28 even carbon atoms, an anteiso-acid series, with a terminal isobutyl group, with odd numbers of carbons from C9 to C31, α-hydroxy normal and iso-acids, like [R—CH(OH)—COOH] with even carbon numbers from about C12 to C32, n-alcohols from C18 to C30, Iso-alcohols from C18 to C26, anteiso-alcohols from C17 to C27 and 1,2 diols. The composition of fatty acids in wool grease is of complex nature given the different acids and alcohols present which can form varied esters.
- To obtain cholesterol of pharmaceutical grade from wool grease is therefore limiting and demands for alternative sources for extraction of cholesterol which is cost-effective and industrially scalable.
- One such source which is preferred in the art are dairy products selected form raw milk, pasteurized milk, raw cream, pasteurized cream, butter oil or anhydrous fat and such like which have large levels of cholesterol. The content of cholesterol in milk fat can vary, typically contains 2-5 gms total cholesterol per 100 grams. Further essentially all of the cholesterol in milk fat is present as free cholesterol with only traces of cholesterol present as an ester.
- Many techniques are employed to extract cholesterol from milk fat such as steam stripping, supercritical fluid extraction (SFE) using carbon dioxide, specific enzymatic cholesterol reductase or adsorption using cyclodextrins. These processes are lengthy, cumbersome and expensive.
- U.S. Pat. No. 5,326,579 disclose a process for the removal of cholesterol from a processed or un-processed dairy product using saponin as adsorbent at a temperature in the range of 35−80° C. and separating the insoluble cholesterol: saponin/diatomaceous earth by filtration or centrifugation. However, 3-β-Cholesterol esters present in the milk fat are found to not complex with saponin. The process described in US′579 does not isolate cholesterol in esterified form.
- U.S. Pat. No. 6,129,945 disclose a process for removing free fatty acids (FFA) and preferably cholesterol from liquid anhydrous animal fats. The process uses a dilute solution of alkali metal base to form a salt of the FFA and then an alkali metal salt to precipitate the FFA from the animal fat. Preferably, a cyclo dextrin is used in the process to remove cholesterol. The process described in US′945 includes first saponification followed by separation of FFA (cholesterol) using beta-cyclo dextrin. The process described in US′945 is based on relatively long reaction time process at low temperature, requires controlled use of the amount of base for saponification which otherwise is detrimental to the yield due to the losses of neutral fat by saponification.
- EP0318326 relates to a process of removing sterols from edible fat, specifically milk fat using a fixed and pulsed carbon column filled with adsorbents selected from carbon impregnated with a metal salt including zinc sulphate, zinc nitrate, zinc chloride, calcium chloride, manganese nitrate, manganese sulphate, manganese chloride; carbon impregnated with water soluble or alcohol soluble organic compounds selected from amides and nucleotides; porous glass, ceramic or plastics; aluminas, silicas, zeolites and magnesia which have/been impregnated with mineral salts and/or selected amides and nucleotides.
- WO2016096988 describe the process for extraction of cholesterol from milk fat which includes saponification which is carried out preferably in a solvent or a mixture of solvent (for example alcohol/water mixture) followed by extraction with at least one non-water miscible solvent at elevated temperature. The process of WO'988 is liquid extraction of cholesterol at elevated temperature and the yields and purity are low.
- In light of the commercial value of pharmaceutical grade cholesterol, which also acts as a precursor for production of vitamin D3, there exists a need in the art to provide cost effective and improved process for extraction of cholesterol from milk fat in high yield and purity. This remains the objective of the invention.
- The objectives of the present invention are met by providing cost effective, solvent free process for extraction of cholesterol from milk fat wherein the cholesterol obtained is substantially free of impurities and can be used in the preparation of vitamin D3.
- Accordingly, the solvent free process for extraction of cholesterol of high purity from milk fat characterized by the process steps comprising;
-
- i. heating unsaponified milk fat with anhydrous calcium chloride in molar ratio ranging from 1:1 to 1:12 to obtain CaCl2-cholesterol adduct; and
- ii. separating cholesterol from the adduct by refluxing in the solvent followed by re-crystallization to yield pure cholesterol.
- In an aspect, the present invention provides pharmaceutical grade cholesterol of milk fat characterized by HPLC purity in the range of 95-98%.
- In another aspect, the present invention provides a process for production of vitamin D3 from pure cholesterol of milk fat obtained by the present invention. Accordingly, cholesterol is converted to 7-dehydrocholesterol (7-DHC; pro-vitamin D3) as per International Patent Publication No. WO 2015/170341, filed by the present Applicant, and converting 7-DHC to vitamin D3 by irradiation.
-
FIG. 1 depicts the chromatogram of Standard (STD) cholesterol. -
FIG. 2 depicts the chromatogram of cholesterol obtained by the present process. - The present invention relates to solvent free process for extraction of cholesterol of high purity from milk fat. The present process avoids the contact of milk fat with potentially harmful solvents in the initial stages that can affect the functionality, flavour or other properties of the milk fat. Further, there is no saponification thereby preventing the use of base, which may lead to losses of the neutral fat resulting in low yields of the desired product. The isolated milk fat free of cholesterol is washed with water to remove traces of inorganic impurities. The residual Milk fat free of cholesterol can be used by the milk industry for their own applications.
- In an embodiment, the present invention relates to cost effective, solvent free process for extraction of cholesterol of high purity from milk fat characterized by the process steps which comprises;
-
- i. heating un-saponified milk fat with anhydrous calcium chloride in the ratio ranging between about 1:2 to about 1:20 to obtain CaCl2-cholesterol adduct; and
- ii. separating cholesterol from the adduct by refluxing in the solvent followed by re-crystallization to yield pure cholesterol.
- The milk fat of the present invention includes skim milk such as fluid skim milk, ultra-filtered skim milk, condensed skim milk and various derivatives of skim milk, whey products such as reconstituted fluid whey, whey powder, whey protein isolates, whole milk, reduced fat, reconstituted non-fat dry milk and the like that contribute significant amounts of cholesterol in these foods. The content of cholesterol typically ranges from 2-5 gms per gm of the milk fat.
- Accordingly, the process comprises heating the sterol containing un-saponified milk fat with anhydrous calcium chloride in molar ratio ranging between about 1:2 to about 1:20, in solvent free medium, to obtain addition product of free cholesterol. The heating is performed at temperature in the range of 40−90° C., preferably 40-80° C., most preferably 75-85° C. for a period of 2-10 hours.
- The reaction mass is then cooled to 40-50° C. and maintained at same temperature for 10-36 hours and filtered. The cholesterol adduct is suspended in organic solvent and refluxed for 1-10 hours, preferably 1-5 hours, more preferably 2-4 hours. The reaction mass is cooled to 0-50° C., preferably at 15-45° C., more preferably at 20-30° C., stirred at same temperature for about 2-3 hours, filtered, washed further with organic solvent and dried under vacuum to obtain cholesterol.
- The isolated crude cholesterol is further purified by crystallization in solvent selected from lower alcohols such as methanol, ethanol, n-propanol, IPA, n-butanol, isobutanol or tert-butanol, preferably methanol or ketones selected from acetone, 2-Butanone, methyl isobutyl ketone, preferably acetone.
- The residual milk fat free of cholesterol obtained after filtration of cholesterol-calcium chloride adduct satisfies the quality standard required by the Milk industry and can be used by Milk industry for their own applications.
- In an embodiment, the cholesterol obtained by the present process is substantially free of impurities and is characterized by HPLC purity in the range of 95-99% as depicted in the comparative tables 1 and 2 below. The pharmaceutical grade cholesterol can be used as precursor for further preparation of vitamin D3.
-
TABLE 1 HPLC data of STD cholesterol (w.r.t FIG. 1) Peak No. time Retention Area Height Area % 1. 10.895 4714241 1020260 99.335 2. 11.140 14800 4917 0.312 3. 11.258 12567 4208 0.265 4. 11.616 2640 739 0.056 5. 11.738 1544 400 0.033 Total 4745792 1030524 100.000 -
TABLE 2 HPLC data of cholesterol obtained by the present process (w.r.t FIG. 1) Peak No. time Retention Area Height Area % 1. 10.893 5311138 1083092 99.337 2. 11.128 4877 1305 0.091 3. 11.246 16260 5626 0.304 4. 11.711 14315 2456 0.268 Total 5346590 1092479 100.000 - In another embodiment, the process for preparation of vitamin D3 from pharmaceutical grade cholesterol obtained from milk fat of the present invention which comprises (a) converting cholesterol to 7-dehydrocholesterol (7-DHC; pro-vitamin D3) as per International Patent Publication No. WO 2015/170341, filed by the present Applicant, and (ii) converting 7-DHC to vitamin D3 by irradiation.
- In the advantageous embodiment of the present invention, the milk fat used for extraction of cholesterol is not exposed to solvents in the initial stages due to which the functionality, flavour or other properties of the milk fat are not disturbed; there is no saponification thereby preventing the use of base, which may lead to losses of the neutral fat resulting in low yields of the desired product; the residual milk fat free of cholesterol of good quality can be used by the Milk Industry for further applications according to their requirement. The cholesterol obtained by the present process is of pharmaceutical grade and can be used as precursor for further preparation of vitamin D3. The process is simple and industrially feasible with minimum work up steps.
- The example herein is provided to illustrate particular aspect of the disclosure and do not limit the scope of the present invention.
- Milk fat (100 gms) and anhydrous calcium chloride (8.5 gms) were heated at 80° C. for 2-4 hours. The reaction mass was cooled to 45° C. and maintained at same temperature for 15 hours. The reaction mass was filtered at 45° C., and the solid residue of cholesterol-adduct was suspended in methanol (100 ml). The reaction mass was refluxed for 4-6 hours, cooled to 25-30° C., stirred at same temperature for 2-3 hours, filtered and washed with methanol (10 ml) to obtain crude cholesterol. The crude cholesterol was recrystallized by dissolving in methanol (100 ml), filtered, washed with 20-50 ml of cold Methanol, dried under vacuum at 45° C. to obtain pure cholesterol.
- Yield: 35 gms
- HPLC Purity: 96-99%.
- It is to be understood that the above description is intended to be illustrative and not restrictive. Many embodiments will be apparent to a person skilled in the art upon reviewing the description. The scope of the invention should therefore, be determined not with reference to the above description, but instead should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201721032630 | 2017-09-14 | ||
IN201721032630 | 2017-09-14 | ||
PCT/IN2018/050590 WO2019053742A1 (en) | 2017-09-14 | 2018-09-12 | Solvent free process for extraction of cholesterol from milk fat |
Publications (2)
Publication Number | Publication Date |
---|---|
US20200377818A1 true US20200377818A1 (en) | 2020-12-03 |
US11629309B2 US11629309B2 (en) | 2023-04-18 |
Family
ID=65723542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/634,812 Active 2038-11-30 US11629309B2 (en) | 2017-09-14 | 2018-09-12 | Solvent free process for extraction of cholesterol from milk fat |
Country Status (4)
Country | Link |
---|---|
US (1) | US11629309B2 (en) |
EP (1) | EP3625241A4 (en) |
JP (1) | JP7038138B2 (en) |
WO (1) | WO2019053742A1 (en) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5829319B2 (en) * | 1974-09-12 | 1983-06-22 | 第一工業製薬株式会社 | cholesterol |
JPS5271500A (en) * | 1975-12-11 | 1977-06-14 | Kanebo Ltd | Purification of colesterol |
JPS5315308A (en) * | 1976-07-27 | 1978-02-13 | Nippon Oil & Fats Co Ltd | Collection of fatty acid esters and cholesterol |
DE2656208A1 (en) | 1976-12-11 | 1978-06-15 | Henkel Kgaa | PROCESS FOR THE ISOLATION OF STERINES FROM FAT PROCESSING RESIDUES |
NZ222728A (en) | 1987-11-27 | 1991-08-27 | New Zealand Dairy Res Inst | Method of removing sterols and or sterol oxides from edible fats and oils |
US5326579A (en) | 1989-10-13 | 1994-07-05 | The Regents Of The University Of California | Process to remove cholesterol from dairy products |
US5045242A (en) * | 1990-01-11 | 1991-09-03 | Steven Roczniak | Removal of cholesterol from edible fats |
DE4139398C1 (en) * | 1991-11-29 | 1993-01-14 | Siegfried Prof. Dr. 8525 Uttenreuth De Peter | |
JP3457690B2 (en) * | 1993-12-16 | 2003-10-20 | 日本精化株式会社 | Method for producing high-purity cholesterol |
JP3154234B2 (en) * | 1994-06-10 | 2001-04-09 | 森永乳業株式会社 | Method for regenerating cyclodextrin |
US6129945A (en) | 1998-12-10 | 2000-10-10 | Michael E. George | Methods to reduce free fatty acids and cholesterol in anhydrous animal fat |
CA2372154A1 (en) | 1999-04-27 | 2000-11-02 | James P. Kutney | Process of purifying phytosterols from wood or plant-derived sources and compositions resulting therefrom |
NZ554744A (en) * | 2007-04-24 | 2009-12-24 | Fonterra Co Operative Group | Dairy product and process for the preparation of gelled emulsions used in food products |
EP2055195A1 (en) | 2007-10-29 | 2009-05-06 | Corman S.A. | Method of reducing the saturated fatty acid content of milk fat, products obtained and applications thereof. |
CN103554207A (en) | 2013-10-30 | 2014-02-05 | 吉安荣威生物科技有限公司 | Lanolin cholesterol production technology |
WO2016096988A1 (en) * | 2014-12-19 | 2016-06-23 | Dsm Ip Assets B.V. | Method of extracting cholesterol from milk fat |
CN107141331A (en) | 2017-07-07 | 2017-09-08 | 赵厚发 | The extracting method of cholesterol in a kind of marine organisms byproduct |
-
2018
- 2018-09-12 US US16/634,812 patent/US11629309B2/en active Active
- 2018-09-12 WO PCT/IN2018/050590 patent/WO2019053742A1/en unknown
- 2018-09-12 EP EP18856309.2A patent/EP3625241A4/en active Pending
- 2018-09-12 JP JP2019556975A patent/JP7038138B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3625241A1 (en) | 2020-03-25 |
EP3625241A4 (en) | 2020-10-21 |
JP7038138B2 (en) | 2022-03-17 |
JP2021501737A (en) | 2021-01-21 |
US11629309B2 (en) | 2023-04-18 |
WO2019053742A1 (en) | 2019-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4664176B2 (en) | Plastic oil composition | |
RU2012120869A (en) | SUNFLOWER FAT WITH HIGH MELT TEMPERATURE FOR CONFECTIONERY | |
JP2013507940A5 (en) | ||
JP6899415B2 (en) | Method for Producing Concentrated Composition of C20-C22 Long Chain Polyunsaturated Fatty Acid and Concentrated Composition of C20-C22 Long Chain Polyunsaturated Fatty Acid | |
JP2000502740A (en) | Mixture of polyunsaturated fatty acids and fatty acid esters without sterol and phosphorus compounds | |
US11718640B2 (en) | Process for extraction of cholesterol from fish oil waste residue | |
US11629309B2 (en) | Solvent free process for extraction of cholesterol from milk fat | |
US10190075B2 (en) | Enrichment of palmitoleic acid and palmitoleic acid derivatives by dry and solvent-aided winterization | |
CA2436650A1 (en) | Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses | |
JP2005531641A (en) | Process for producing hydroxytyrosol ester, ester obtained by the process and use of the ester | |
JP5683880B2 (en) | Oil growth inhibitor | |
JP2002020782A (en) | Method for solid-liquid separation of oil and fat composition | |
JPH0320397A (en) | Highly fresh fish oil containing fish phospholipid and its preparation | |
JPH05230494A (en) | Method for removing sterol from vegetable and animal fat | |
JP4170599B2 (en) | Isolation of oryzanol from rice bran oil soapstock | |
HUE026243T2 (en) | Process for preparing conjugated fatty acids and esters thereof | |
WO2016096988A1 (en) | Method of extracting cholesterol from milk fat | |
EP2758480B1 (en) | Edible oil with a high concentration of poly-unsaturated fatty acids | |
US2347460A (en) | Process for treating fat-soluble vitamin-containing oils | |
JP4190893B2 (en) | Sterol composition, oil and fat composition and food containing the same | |
JP6283510B2 (en) | Method for producing triterpene alcohol-containing fats and oils | |
PL217384B1 (en) | New diacylo-sn-glycero-3-phosphocholine and process for the preparation thereof | |
JPH03229800A (en) | Preparation of animal fat or oil with decreased cholesterol content | |
JP2016138167A (en) | Powder raw material | |
FR2840904A1 (en) | Glucose fatty acid esters active in preventing hair loss and aiding hair regrowth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |